|1.||Rotondo, Dino: 1 article (06/2013)|
|2.||Brown, Kirsten L: 1 article (06/2013)|
|3.||Davidson, Jillian: 1 article (06/2013)|
|4.||Bezuglov, V V: 1 article (05/2011)|
|5.||Frumkina, L E: 1 article (05/2011)|
|6.||Lizhin, A A: 1 article (05/2011)|
|7.||Andrianova, E L: 1 article (05/2011)|
|8.||Genrikhs, E E: 1 article (05/2011)|
|9.||Bobrov, M Yu: 1 article (05/2011)|
|10.||Khaspekov, L G: 1 article (05/2011)|
06/01/2013 - "Since prostaglandin E2 has potent immunosuppressive/immunomodulating actions, the aim of the present study was to determine whether the derivative, prostaglandin E2 ethanolamide (PGE2-EA), could modulate the production of the pro-inflammatory cytokine tumour necrosis factor-α in human blood and human monocytic cells and indicate whether this action involved the same receptor systems/signals as PGE2. "
05/01/2011 - "Prostamide E2 did not modulate the survival rate of glioma cells, while anandamide produced a cytotoxic effect. "
05/01/2011 - "We studied the effects of endocannabinoid anandamide and its cyclooxygenase derivative prostamide E2 on cultured cerebellar granular cells and C6 glioma cells from rats. "
|3.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)